Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 2,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Dysplasia Mild Clear all

Conditions: Ankle Sprain
Interventions: Ketoprofen Patch, Placebo Patch; Drug · Other
Lead sponsor: Hisamitsu Pharmaceutical Co., Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 25
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 21 more

Conditions: Mild Hepatic Encephalopathy
Interventions: AST-120; Drug
Lead sponsor: Ocera Therapeutics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 38
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fresno, California + 29 more

Conditions: BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency, Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe, Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe
Interventions: clindamycin phosphate vaginal cream 2%, placebo; Drug · Other
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 604 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 15
States / cities: Birmingham, Alabama • La Mesa, California • San Diego, California + 12 more

Conditions: Alzheimer's Disease
Interventions: CERE-110: Adeno-Associated Virus Delivery of NGF; Genetic
Lead sponsor: Sangamo Therapeutics; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 2
States / cities: San Diego, California • Chicago, Illinois

Conditions: Alzheimer's Disease
Interventions: Piromelatine 20 mg, Placebo; Drug
Lead sponsor: Neurim Pharmaceuticals Ltd.; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 32
States / cities: Costa Mesa, California • Long Beach, California • San Diego, California + 21 more

Conditions: Mild Cognitive Impairment
Interventions: VR cognitive training platform; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
Interventions: natural product combination-1 (NPC1); Combination Product
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 55 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mild Cognitive Impairment
Interventions: Pioglitazone, Placebo, Endurance Exercise Training; Drug · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 55 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Lumbar Spinal Stenosis
Interventions: lumbar decompression; Procedure
Lead sponsor: Vertos Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 8
States / cities: Merritt Island, Florida • Baltimore, Maryland • Festus, Missouri + 5 more

Conditions: Mild Traumatic Brain Injury, Post Traumatic Stress Disorder
Interventions: of Lactobacillus reuteri (L. reuteri; DSM 17938), Sunflower and medium chain triglyceride oils; Dietary Supplement · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Brain Injuries, Traumatic
Interventions: Not listed
Lead sponsor: Banyan Biomarkers, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Mild Cognitive Impairment
Interventions: Deferiprone, Placebo phase; Drug · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 65 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Acute Pain
Interventions: Diclofenac Sodium Patch, Matching Placebo Patch; Drug
Lead sponsor: Cerimon Pharmaceuticals; Industry
Eligibility: 17 Years to 75 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Brain Concussion, Mild Traumatic Brain Injury
Interventions: BrainPulse; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Boston, Massachusetts • Cincinnati, Ohio • Johnson City, Tennessee

Conditions: Parkinson Disease, Mild Cognitive Impairment
Interventions: Accelerated intermittent theta-burst stimulation (iTBS) rTMS to right superior parietal lobule (rSPL); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 50 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cognitive Assessment, Psychological Function, GI Health
Interventions: Pecan snack, Pretzel snack; Biological
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 50 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Major Depression, Mental Health
Interventions: Provigil; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 4
States / cities: Stanford, California • Atlanta, Georgia • New York, New York + 1 more

Conditions: Renal Impairment
Interventions: Topirmate and Phentermine; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 19 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 4
States / cities: Anaheim, California • Miami, Florida • Orlando, Florida + 1 more

Conditions: Mild Traumatic Brain Injury, Hyperbaric Oxygen Therapy, Depression
Interventions: Oxygen 100 % Gas for Inhalation, Hyperbaric Oxygen Therapy Chamber; Drug · Device
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Healthy
Interventions: Cooling pack activated Excel Cryo Cooling Collar; Device
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 60 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Brain Concussion
Interventions: MedX Health Console model 1100, MedX Health Console model 1100-placebo; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 11 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Boston, Massachusetts • Waltham, Massachusetts

Conditions: Asthma
Interventions: AMG 691, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 15
States / cities: Lake Forest, California • Aventura, Florida • Palmetto Bay, Florida + 12 more

Conditions: Cerebrovascular Disease, Mild Cognitive Impairment
Interventions: Heart Health Intervention; Behavioral
Lead sponsor: Gregory Jicha, 323-5550; Other
Eligibility: 55 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Alzheimer's Disease
Interventions: CHF 5074 1x, CHF 5074 2x, CHF 5074 3x, Placebo; Drug
Lead sponsor: CERESPIR; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 5
States / cities: St. Petersburg, Florida • Eatontown, New Jersey • Monroe Twp, New Jersey + 2 more

Search by objective public record fields.

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

AST-120 Used to Treat Mild Hepatic Encephalopathy

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

A Health Game Intervention for Cancer and Post-ICU Patients Suffering From Acute Cognitive Impairment

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)

MiDAS II (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Biological Signatures, Probiotic Among Those With mTBI and PTSD

Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI

A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment

Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion

Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)

Superior Parietal iTBS for PD-MCI

Snacks and Brain Health

Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy

Temperature Evaluation by MRI Thermometry During Cervical Cooling

LED Therapy for the Treatment of Concussive Brain Injury

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074